Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev

Read MoreHide Full Article

For Immediate Release

Chicago, IL – August 7, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. (AAPL - Free Report) , Mastercard Incorporated (MA - Free Report) , Eli Lilly and Company (LLY - Free Report) , PetroChina Company Limited (PTR - Free Report) and Anheuser-Busch InBev SA/NV (BUD - Free Report) .

Here are highlights from Thursday’s Analyst Blog:

Top Stock Reports for Apple, Mastercard and Eli Lilly

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Mastercard and Eli Lilly. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Apple shares have outperformed the S&P 500 year to date (+51.5% vs. +3.3%), with the stock benefiting from momentum in the Services business, strong adoption of Apple Pay and growing Apple Music subscriber base.

Apple’s third-quarter fiscal 2020 results reflected continued momentum in the Services segment, driven by a robust performance of App Store, Apple Music, video and cloud services. iPad and Mac also contributed strongly to the quarterly results. Moreover, iPhone sales recovered, driven by strong demand in May and June, primarily for iPhone SE.

Apple devices also continued to gain traction among enterprises, particularly healthcare providers. Apple didn’t provide any guidance due to uncertainties triggered by the pandemic. However, it expects fiscal fourth-quarter iPhone sales to benefit from strong demand for iPhone SE. Apple stated that sale of new iPhones will begin a few weeks later against the usual late September. It also expects iPad and Mac to post strong year-over-year growth.

(You can read the full research report on Apple here >>>)

Shares of Mastercard have lost -0.1% over the past six months against the Zacks Financial Transaction Services industry’s fall of -4.2%. The Zacks analyst believes that the company is gaining from transition in payments from physical to digital. Investment in technology keeps it at the forefront of the rapidly-evolving payments industry.

Mastercard’s earnings of $1.36 per share beat the Zacks Consensus Estimate by 18.3% but were down 26% year over year, due to a contraction in gross dollar volume, lower switched transactions and a weak cross-border business.

Mastercard is also witnessing buoyant demand for its Data & Analytics and Cyber solutions. Its solid capital position enables investment in business. However, escalating costs might put pressure on the company’s margins. It also cancelled its annual 2020 outlook for net revenues and operating expense due to coronavirus-induced business loss.

(You can read the full research report on Mastercard here >>>)

Eli Lilly shares have lost -0.6% over the past three months against the Zacks Large Cap Pharmaceuticals industry’s rise of +3.3%. The Zacks analyst believes that generic competition for several drugs, rising pricing pressure in the United States, and price cuts in some international markets like China, Japan and Europe are some top-line headwinds in 2020.

Lilly beat Q2 estimates for earnings but missed the same for sales. Reduction in new prescription trends of several medicines hurt sales in Q2. However, volume trends are likely to improve in the second half.

Lilly still expects revenue growth to be driven by higher demand for drugs like Trulicity, Taltz, and others and from product launches. Lilly is making significant pipeline progress including its efforts to make therapies to treat COVID-19. It is regularly adding promising new pipeline assets through business development deals.

(You can read the full research report on Eli Lilly here >>>)

Other noteworthy reports we are featuring today include PetroChina and Anheuser-Busch InBev.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                             

http://www.zacks.com                                        

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.